Expres2ion Biotech Hldg Stock Working Capital
| 5JD Stock | EUR 1.77 0.06 3.28% |
EXPRES2ION BIOTECH HLDG fundamentals help investors to digest information that contributes to EXPRES2ION BIOTECH's financial success or failures. It also enables traders to predict the movement of EXPRES2ION Stock. The fundamental analysis module provides a way to measure EXPRES2ION BIOTECH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EXPRES2ION BIOTECH stock.
EXPRES2ION |
EXPRES2ION BIOTECH HLDG Company Working Capital Analysis
EXPRES2ION BIOTECH's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, EXPRES2ION BIOTECH HLDG has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The working capital for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
EXPRES2ION Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.34 | |||
| Shares Outstanding | 37.15 M | |||
| Shares Owned By Institutions | 1.71 % | |||
| Gross Profit | 6.22 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 12.79 X | |||
| Number Of Employees | 27 | |||
| Beta | 1.46 | |||
| Market Capitalization | 44 M |
About EXPRES2ION BIOTECH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EXPRES2ION BIOTECH HLDG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXPRES2ION BIOTECH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXPRES2ION BIOTECH HLDG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in EXPRES2ION Stock
EXPRES2ION BIOTECH financial ratios help investors to determine whether EXPRES2ION Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EXPRES2ION with respect to the benefits of owning EXPRES2ION BIOTECH security.